An overview of ethical review committees in Japan: examining the certification applications of ethical review committees.


Journal

Nagoya journal of medical science
ISSN: 2186-3326
Titre abrégé: Nagoya J Med Sci
Pays: Japan
ID NLM: 0412011

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 17 3 2020
Statut: ppublish

Résumé

The survey involves examining the applications from 142 institutions that have consented to make available all certification applications from 2015 and 2016 to a research project for building a certification system for an ethics committee run by the Agency for Medical Research and Development. The number of certified institutions is 20 (14.1%). In the applications from uncertified institutions, there are cases in which requirements of ethics guidelines are unmet, and there is insufficient information provided on regulation and procedure. An analysis of the committee members who can contribute as members of the general public (general public committee members) has indicated that the number of committee members who do not belong to an institution in which an ethics committee is instituted (external committee members) is 41 (95.7%) among the certified institutions and 224 (84.5%) among the uncertified institutions. The proportion of general public committee members drawn internally from institutions tends to be higher among uncertified institutions. While a separate committee examined conflicts of interest in research in 19 certified institutions (95.0%), such conflicts were found in 41 uncertified institutions (33.9%) by the ethics committee. The survey confirms that the challenge lies in increasing the number of external committee members and in further improving the system to manage conflicts of interest, and the education and training regime.

Identifiants

pubmed: 31579340
doi: 10.18999/nagjms.81.3.501
pmc: PMC6728202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-509

Déclaration de conflit d'intérêts

The authors have no conflicts of interest directly relevant to the content of this manuscript.

Références

IRB. 1995 May-Jun;17(3):1-6
pubmed: 11654267
Clin Transl Sci. 2017 May;10(3):130-132
pubmed: 28083989
AJOB Empir Bioeth. 2018 Jul-Sep;9(3):164-172
pubmed: 30285561
Pediatr Investig. 2018 May 11;2(1):46-51
pubmed: 32851230

Auteurs

Yoshihiko Iijima (Y)

Medical Research and Clinical Promotion Office, Nagoya University Hospital, Nagoya, Japan.

Kazuyoshi Ogasawara (K)

Medical Research and Clinical Promotion Office, Nagoya University Hospital, Nagoya, Japan.

Soichiro Toda (S)

Clinical Research Innovation and Education Center, Tohoku University Hospital, Sendai, Japan.

Tadao Takano (T)

Clinical Research Innovation and Education Center, Tohoku University Hospital, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH